Trial intelligence / Profile preview

PRGF for MCL Tear Healing

NCT00743886Phase 3Withdrawn

Sponsor
Meir Medical Center
Start
Jan 2008
Primary completion
Feb 2009
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of PRGF-Endoret in medial collateral ligament tear, sponsored by Meir Medical Center. Planned start Jan 2008; status: withdrawn.

02

Drugs

PRGF-Endoret
03

Conditions

medial collateral ligament tear

Beyond the preview

Go deeper on NCT00743886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00743886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call